Abstract
After consideration of the tertiary structure of the pY+3 binding pocket in SH2 domains, isoleucine of Ac-pYEEIE was replaced with various unnatural aliphatic amino acids and the binding affinities for Lck, Src, and Fyn SH2 domains were measured. We determined the characteristics of the amino acid at the pY+3 position in the phosphopeptide ligands for the specificity for the SH2 domains.
Keywords: sh2 domain, specificity, phosphopeptide, ligand, lck, src, fyn
Protein & Peptide Letters
Title: The Relationship Between the Py3 Amino Acid in the Phosphopeptide Ligands and the Specificity for Various Sh2 Domains
Volume: 11 Issue: 6
Author(s): Keun-Hyeung Lee and See-Hyoung Park
Affiliation:
Keywords: sh2 domain, specificity, phosphopeptide, ligand, lck, src, fyn
Abstract: After consideration of the tertiary structure of the pY+3 binding pocket in SH2 domains, isoleucine of Ac-pYEEIE was replaced with various unnatural aliphatic amino acids and the binding affinities for Lck, Src, and Fyn SH2 domains were measured. We determined the characteristics of the amino acid at the pY+3 position in the phosphopeptide ligands for the specificity for the SH2 domains.
Export Options
About this article
Cite this article as:
Lee Keun-Hyeung and Park See-Hyoung, The Relationship Between the Py3 Amino Acid in the Phosphopeptide Ligands and the Specificity for Various Sh2 Domains, Protein & Peptide Letters 2004; 11 (6) . https://dx.doi.org/10.2174/0929866043406337
DOI https://dx.doi.org/10.2174/0929866043406337 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy
Current Drug Targets Strategies for Recruitment of Stem Cells to Treat Myocardial Infarction
Current Pharmaceutical Design Clinical Trials in Irritable Bowel Syndrome: A Review
Reviews on Recent Clinical Trials Interactome Analysis and Docking Site Prediction of Cockayne Syndrome A (CSA) Proteins in <i>Arabidopsis thaliana</i>
Current Proteomics Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy
Current HIV Research Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases
Current Pharmaceutical Design Drug Targets in Severe Acute Respiratory Syndrome (SARS) Virus and other Coronavirus Infections
Infectious Disorders - Drug Targets HCN Pacemaker Channels and Pain: A Drug Discovery Perspective
Current Pharmaceutical Design Systems Biology of Apoptosis and Survival: Implications for Drug Development
Current Pharmaceutical Design Molecular Mechanisms of Glucocorticoids Action: From Basic Research to Clinical Implications
Current Immunology Reviews (Discontinued) Nanosuspensions as a Versatile Carrier based Drug Delivery System - An Overview
Current Drug Delivery The Role of Stromal Components in Pancreatic Cancer Progression
Anti-Cancer Agents in Medicinal Chemistry Receptor Tyrosine Kinases are Signaling Intermediates of G Protein- Coupled Receptors
Current Pharmaceutical Design HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy
Current Gene Therapy Curcumin Against Malaria: From Traditional Medicine to Development of Synthetic Analogs; A Bioorganic Approach
Current Traditional Medicine The Role of Coagulation in Ventilator-Associated Pneumonia
Current Respiratory Medicine Reviews Transcriptional Control of Metabolism, Inflammation and the Immune Response: The Role of PPARs
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Evidences and Opinions for Adjuvant Therapy in Pancreatic Cancer
Current Drug Targets Targeting Synthetic Lethality in DNA Damage Repair Pathways as an Anti-Cancer Strategy
Current Drug Targets Anti-Cancer
Current Bioactive Compounds